President Joseph R. Biden Jr. proclaimed September Prostate Cancer Awareness Month, highlighting the need for increased awareness of prostate cancer symptoms to facilitate early detection and treatment as well as the disparities that accompany the disease.

David R. Wise, MD, PhD, a medical oncologist at NYU Langone Health’s Perlmutter Cancer Center, speaks with the Association of Community Cancer Centers’ blog, ACCCBuzz, about the progress made in screening for and treating prostate cancer, including androgen receptor–directed therapies and genetic testing to personalize treatment, and where he thinks there needs to be improvement.

“The priority should be placed on investment in research,” says Dr. Wise, also assistant professor in the Departments of Medicine and Urology at NYU Grossman School of Medicine. “Without more research into the mechanisms of cancer, we are not going to find the game-changing treatments we need. Research is hard and most of it fails, so we need to cast a wide net.”

Read more from ACCCBuzz.